Eli Lilly and Company (NYSE:LLY) is one of the most profitable growth stocks to buy according to billionaires. On August 1, ...

The dulaglutide biosimilar LY05008 demonstrated equivalent efficacy in reducing HbA1c, along with comparable safety and immunogenicity profiles, to the reference drug dulaglutide in Chinese adults ...

SURPASS-CVOT evaluated the efficacy and safety of tirzepatide compared with dulaglutide in adults with T2D and a confirmed ASCVD.

For older adults with type 2 diabetes, glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with ...

在诺和诺德（Novo Nordisk）宣布下调业绩增速指引，礼来公司（Eli Lilly and Company）公布产品替尔泊肽（Tirzepatide）的心血管保护作用非劣效于度拉糖肽（Dulaglutide）之后，8月1日，博瑞医药宣布将旗下明星产品BGM0504授权给华润三九，累计的研发投入里程碑付款最高为2.8亿元。 2.8亿元让这起商业授权快速获得了关注。累计里程碑付款代表了某一款产品 ...

An older woman with dementia and type 2 diabetes was started on semaglutide and subsequently developed severe psychological and physical symptoms, including apathy, significant weight loss and ...

Researchers introduced the PREVENT risk age equations to help determine risk of cardiovascular disease. (JAMA Cardiology) A ...

Q: I’m developing Parkinson’s disease. The symptoms are intermittent and mild, but I want to do everything I can to keep them that way. Can you let me know what ...

A Phase III, international, randomized clinical trial assessed the safety and efficacy of canagliflozin for the treatment of ...

Despite this, one in five young adults who meet the criteria for the drugs are uninsured and one-third denied having a routine place for healthcare.

Topline results from the SURPASS-CVOT trial reveal that once-weekly tirzepatide (Mounjaro) has a cardiovascular risk profile ...

Glucagon-like peptide-1 (GLP-1) inhibitors have proven effective in preventing cardiovascular events, leading to experts ...